Short-term continuous infusion of human parathyroid hormone 1–34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice
Catabolism
DOI:
10.1677/joe.1.06270
Publication Date:
2005-08-31T17:23:50Z
AUTHORS (7)
ABSTRACT
Parathyroid hormone (PTH) stimulates bone resorption as well formation in vivo and organ culture. The catabolic actions of PTH have been recognized patients with hyperparathyroidism, or acute infusion the N-terminal 1-34 fragment human (hPTH1-34). Whereas anabolic daily injection studied both humans mice, on murine remain to be defined. To do this we sought create a model short-term, sustained hyperparathyroidism using osmotic pumps. We treated 10-week-old female C57BL/J6 mice continuous hPTH1-34 (8.1 pmol/0.25 microl per h, equivalent 40 microg/kg day) vehicle for 2 weeks, Alzet Bone mineral density (BMD), serum total calcium, hPTH1-34, mouse intact (mPTH1-84), osteocalcin tartrate-resistant acid phosphatase (mTRAP) activity, microarchitectural variables distal femur were measured. Separately, compared effects intermittent (40 BMD markers. Exogenous was detected only PTH-infused mice. Both treatment markedly suppressed endogenous mPTH1-84, but latter induced hypercalcemia. Daily significantly increased mTRAP, while showed strong trend stimulate slight non-significant increase osteocalcin. There significant differences at all sites between animals same dose hPTH1-34. Micro-computed tomography (muCT) analysis femurs revealed that decreased trabecular connectivity (P<0.05). Thus, response quite different from seen injection. Short-term appears good study mechanisms underlying action
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (54)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....